A pharmacological activator of AMP-activated protein kinase (AMPK) induces astrocyte stellation
- 7 September 2007
- journal article
- Published by Elsevier in Brain Research
- Vol. 1168, 1-10
- https://doi.org/10.1016/j.brainres.2007.06.087
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- RhoA inactivation is crucial to manganese-induced astrocyte stellationBiochemical and Biophysical Research Communications, 2005
- TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPaseThe Journal of cell biology, 2004
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature Cell Biology, 2004
- LKB1 tumor suppressor protein: PARtaker in cell polarityTrends in Cell Biology, 2004
- RhoA inhibition is a key step in pituicyte stellation induced by A1-type adenosine receptor activationGlia, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Inhibition of Vanadate-Induced Astrocytic Stress Fiber Formation by C3 ADP-RibosyltransferaseBiochemical and Biophysical Research Communications, 1996
- Glutamate blocks astroglial stellation: Effect of glutamate uptake and volume changesGlia, 1994
- The Early Reactions of Non-Neuronal Cells to Brain InjuryAnnual Review of Neuroscience, 1994
- Effects of Neurotransmitters on Astrocyte Glycogen Stores In VitroJournal of Neurochemistry, 1988